Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
NCT02395458 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 142
Last updated 2015-03-23
Summary
Clinical trial to compare efficacy on eradicating Helicobacter pylori with two antibiotic strategies: sequential with amoxicillin and omeprazole 5 days and clarithromycin with metronidazole and omeprazole 5 days or omeprazole with clarithromycin and amoxicillin 14 days.
Conditions
- Helicobacter Infections
Interventions
- DRUG
-
Sequential therapy
Patient receive Omeprazole plus amoxicillin during 5 days and then omeprazole plus clarithromycin and metronidazole during another 5 days
- DRUG
-
Triple therapy
Patient receive Omeprazole plus amoxicillin and Clarithromycin during 14 days
Sponsors & Collaborators
-
Coordinación de Investigación en Salud, Mexico
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
More Related Trials
-
5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
NCT01544517 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT04991584 ·Status: UNKNOWN ·Phase: NA
-
Concomitant Versus Hybrid Regimen for H. Pylori Eradication
NCT03592069 ·Status: COMPLETED ·Phase: PHASE4
-
Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection
NCT01481844 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
NCT02922699 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori
NCT01042184 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
NCT02483715 ·Status: COMPLETED ·Phase: PHASE4
-
RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
NCT02092506 ·Status: COMPLETED ·Phase: PHASE4
-
Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.
NCT02726269 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
NCT02108184 ·Status: UNKNOWN ·Phase: PHASE4
-
10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
NCT03134378 ·Status: UNKNOWN ·Phase: PHASE4
-
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
NCT05926804 ·Status: RECRUITING ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
NCT04090021 ·Status: UNKNOWN ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
NCT03139253 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
NCT06315478 ·Status: COMPLETED ·Phase: PHASE4
-
Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT01723059 ·Status: UNKNOWN ·Phase: NA
-
Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
NCT01906879 ·Status: UNKNOWN ·Phase: PHASE4
-
Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial
NCT00403364 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
NCT02576236 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT03726099 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
NCT02490839 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
NCT02711176 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4